SGC in the News

Explore our news articles and stay connected with the SGC.

Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?

 

SGC releases TEPs to support research into new drug discovery targets

June 16th, 2017- SGC’s Target Enabling Package (TEP) Evaluation Group has approved five new TEPs for protein targets related to cancer, metabolic diseases and neuropsychiatric disorders.

TEPs enable scientists to research understudied proteins that have been genetically…

SGC Scientists Report the First Chemical Probe for PCAF Bromodomain

Oxford, UK, January 12, 2017, Scientists from the Structural Genomics Consortium (SGC) and Oxford University report the first potent and selective chemical probe for the bromodomain of PCAF in an article published in Angewandte Chemie International Edition.

PCAF is a multidomain protein.…

Oxford AHSN recognizes the SGC with its annual Public-Private Collaboration Award

SGC wins Oxford AHSN Public-Private Collaboration Award
Shown left-to-right: John Harris (CEO of OBN), Dr. Rab Prinjha (VP of GSK Medicines Research Centre), Chas Bountra (Director SGC Oxford), Dr. Paul Durrands (COO Oxford AHSN), and Dr. Wen Hwa Lee (Director Disease Foundations…

Categories